🇺🇸 FDA

Intelligence · Patent portfolio

Regeneron UK Patents

Full USPTO pharma patent portfolio for Regeneron UK — grant dates, expiration, and drug cross-links.

Patents
837
Expiring ≤24m
26

Quick answer

Regeneron UK has 837 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 26 expire within 24 months — use filters for patent-cliff planning.

Page 18 of 18

  1. US 6627415

    TIE-2 ligands, methods of making and uses thereof

    Expires Mon Sep 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6610510

    Morphogenic proteins

    Expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6602683

    Biologically active Eph family ligands

    Expires Mon Jul 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6602687

    DNA encoding human ciliary neurotrophic factor and method for producing the protein encoded thereby

    Expires Mon Jul 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6472179

    Receptor based antagonists and methods of making and using

    Expires Mon Oct 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6472178

    Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof

    Expires Mon Oct 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6455035

    Angiopoietins and methods of use thereof

    Expires Mon Sep 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6440702

    Nucleic acids encoding modified ciliary neurotrophic factors

    Expires Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6441137

    Expressed ligand-vascular intercellular signalling molecule

    Expires Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6432667

    Polynucleotide encoding TIE-2 ligand-4

    Expires Mon Aug 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6433143

    Tie-2 ligands

    Expires Mon Aug 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6413740

    Tyrosine kinase receptors and ligands

    Expires Mon Jun 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6410510

    Administration modified ciliary neurotrophic factors

    Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6316206

    Method for screening comprising cells expressing the CNTF receptor

    Expires Mon Nov 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6265564

    Expressed ligand-vascular intercellular signalling molecule

    Expires Mon Jul 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6207413

    Nucleic acids encoding novel orphan cytokine receptors

    Expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6166185

    Antibodies to human TIE-2 ligands

    Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6143714

    Methods of using hepatocyte growth factor to promote survival, growth and differentiation of motor neurons

    Expires Mon Nov 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6077829

    Stable pharmaceutical composition of BDNF

    Expires Mon Jun 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6060276

    Nucleic acids encoding novel orphan cytokine receptors

    Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6022694

    Assay for ligands to tyrosine kinase receptors

    Expires Mon Feb 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Regeneron UK have?

837 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron UK patents expire?

26 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.